The aging population, increased rates of cancer screenings, new procedures and other factors, are driving an increase in service volumes. Unlike other service lines, Digestive Health is poised for significant growth across care settings.
Still, hospitals are struggling to capitalize on this opportunity. Payer pressure, rising patient sensitivity around price and access, are shifting GI screenings and diagnostics out of the hospital to lower-cost, higher-throughput sites. Rising patient demand for GI services will only accentuate the effects of this shift over time. Without planning around this shift, hospitals and health systems risk losing critical screening and surgical referrals.
Hospital leaders must adopt new strategies for program growth. This conference designed to provide a strategic framework for developing a best-in-class center or program.
Through industry experience and discussion of best practices, attendees will hear from top service line leaders and innovators, Developing, Operating and Advancing Digestive Health Centers, will deliver sound strategy and business guidance for driving excellence in Digestive Health service line development and management.
Advocate Illinois Masonic Medical Center’s Digestive Health Institute offers a range of expertise. The Institute is a partnership between the Gastroenterology Lab and Colorectal Surgery. Their gastroenterologists and surgeons are committed to quality and innovation in gastrointestinal (GI) diagnosis and treatment.
Their physicians offer a breadth of knowledge and expertise on GI-related conditions, addressing everything from heartburn to gallstones to colorectal cancers.
With timely, accurate diagnoses and advanced treatment methods, patients stay disease-free and get back to their daily routine quickly. Learn why patients your trust in the Digestive Health Institute for their GI care.
A conference curriculum consisting of the latest information and processes to succeed in the changing health care environment, including:
This conference is researched and designed for CEOs, COOs, CMOs, CNOs, Administrators, Chairs, Vice Presidents, Directors and Managers within hospitals, health systems, federal and state agencies. Academic Medical Centers, Teaching Hospitals, and Community Hospitals and allied professionals dedicated to the prevention, diagnosis, treatment and management of digestive diseases, including:
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline. We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.
As “The Trusted Resource for Emerging Technology and Clinical Applications in Medical Imaging and Radiation Oncology,” Imaging Technology News (ITN) showcases the latest, most innovative diagnostic & therapeutic technologies and service solutions. ITN is edited for professionals in radiology/medical imaging, therapeutic radiology, business administration and IT in hospitals, freestanding imaging and radiation oncology centers and purchasing organizations. Features include Comparison Charts, Technology Overviews, Advances In, Business & Economics, Case Studies and more.
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA has grown to include more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology.